Showing results (121-130 of 133) with videos related to
Sort By:
Pageof 14
Journal for Immunotherapy of Cancer|September 15, 2020
Identification of dual positive CD19+/CD3+ T cells in a leukapheresis product undergoing CAR transduction: a case reportLiora Schultz, Shabnum Patel, Kara Lynn Davis, et al.American Journal of Clinical Dermatology|September 3, 2025
Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 WeeksAlan D Irvine, Vimal H Prajapati, Emma Guttman-Yassky, et al.International Journal of Sports Physical Therapy|May 5, 2026
Countermovement Jump and Quantitative Electroencephalography Assessment in Division I Football Athletes: An Exploratory Neurophysiological Study of Return‑to‑Play ReadinessRobert E Mangine, Bradley T Jacobs, James A Tersak, et al.Wilderness & Environmental Medicine|July 14, 2025
Space Oncology: A Comprehensive Scoping ReviewNafise Niknam, Hossein Akbarialiabad, Mohsen Farjoud Kouhanjani, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptorJames N Kochenderfer, Mark E Dudley, Sadik H Kassim, et al.Blood|July 5, 2024
A phase 1 clinical trial of NKTR-255 with CD19-22 CAR T-cell therapy for refractory B-cell acute lymphoblastic leukemiaHrishikesh Srinagesh, Clayton Jackson, Parveen Shiraz, et al.Cytotherapy|November 5, 2025
Outcomes following CD22 CAR T-cells in B-ALL: a tale of two manufacturing strategiesAlexandra Dreyzin, Anne Marijn Kramer, Bonnie Yates, et al.Nature Medicine|July 27, 2021
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trialJay Y Spiegel, Shabnum Patel, Lori Muffly, et al.Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention|January 10, 2020
Burden of injury along the development spectrum: associations between the Socio-demographic Index and disability-adjusted life year estimates from the Global Burden of Disease Study 2017Juanita A Haagsma, Spencer L James, Chris D Castle, et al.Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention|August 26, 2020
Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 studySpencer L James, Chris D Castle, Zachary V Dingels, et al.Pageof 14